caa a22 4500 606247319 CHVBK 20210128101344.0 cr unu---uuuuu 210128e20151201xx s 000 0 eng 10.1007/s12262-013-0833-4 doi (NATIONALLICENCE)springer-10.1007/s12262-013-0833-4 Obesity Should Not Prevent from TRAM Flap Breast Reconstruction in Developing Countries [Elektronische Daten] [Sadaf Alipour, Ramesh Omranipour, Rahim Akrami] Transverse rectus abdominis musculocutaneous (TRAM) flap is the most common procedure performed for breast reconstruction after mastectomy for breast cancer. Obesity is a relative contraindication, and complex modifications have been proposed in the pedicled technique for obese patients. We studied ischemic complications in our patients to investigate the effect of body weight on the outcome of TRAM flap breast reconstruction. Pertinent data from medical records of patients receiving a TRAM flap surgery from 1986 to 2011 were extracted. Patients were divided into three groups based on the body mass index (BMI): normal (<25kg/m2), overweight (25-29.9kg/m2), and obese (>30kg/m2). Flap necrosis is defined as any visible nonviable tissue in the reconstructed breast. It was observed that 117 patients had received TRAM flap reconstruction. Fifty-eight patients were excluded. Of the remaining 59 cases, 24 had normal BMI, 21 were overweight, and 14 were obese. No patient was found to develop flap necrosis. Outcome of TRAM flap breast reconstruction in obese patients is similar to nonobese patients. No major necrosis in need of reoperation was identified in the studied obese patients. It was concluded that categorizing obesity as a relative contraindication to TRAM flap breast reconstruction should be revisited based on larger cohort studies. Association of Surgeons of India, 2013 Breast neoplasm nationallicence Breast cancer nationallicence Breast reconstruction nationallicence TRAM flap nationallicence Obesity nationallicence Alipour Sadaf Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran aut Omranipour Ramesh Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran aut Akrami Rahim Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran aut Indian Journal of Surgery Springer India 77(2015-12-01), 341-344 0972-2068 77<341 2015 77 12262 https://doi.org/10.1007/s12262-013-0833-4 text/html Onlinezugriff via DOI BK010053 XK010053 XK010000 Metadata rights reserved Springer special CC-BY-NC licence nationallicence 1 research-article jats NATIONALLICENCE NATIONALLICENCE NL-springer NATIONALLICENCE 856 40 https://doi.org/10.1007/s12262-013-0833-4 text/html Onlinezugriff via DOI NATIONALLICENCE 700 1- Alipour Sadaf Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran aut NATIONALLICENCE 700 1- Omranipour Ramesh Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran aut NATIONALLICENCE 700 1- Akrami Rahim Cancer Research Center, Cancer Institute, Tehran University of Medical Sciences, Tehran, Islamic Republic of Iran aut NATIONALLICENCE 773 0- Indian Journal of Surgery Springer India 77(2015-12-01), 341-344 0972-2068 77<341 2015 77 12262